The mechanism of leptin in NAFLD has been supported by a large body of experimental data, and clinical studies on leptin and NAFLD have focused on the association of leptin or leptin receptor levels with NAFLD. This evidence concerns the gene LEPR and metabolic dysfunction-associated steatotic liver disease.